Phosphagenics' core technology is built around the science and application of phosphorylation, a process where the addition of a phosphate group has been found to enhance the bioavailability, activity and safety of existing pharmaceuticals and nutraceuticals, as well as to assist in the production of drug delivery platforms.
Phosphagenics' shares are listed on the Australian Stock Exchange (POH) and the London Stock Exchange's Alternative Investment Market (PSG). An ADR - Level 1 program was established in the U.S. with The Bank of New York Mellon (PPGNY) for U.S. investors to trade in Phosphagenics' stock on the 'over-the-counter' market. In July 2007, this was upgraded to the International OTCQX, a new premium market tier in the U.S. for international exchange-listed companies, operated by Pink Sheets, LLC.
O Relatório do Mercado Australiano de 7 de Fevereiro de 2011 inclui: Automotive Technology Group Limited (ASX:ATJ) anunciou que o Sprintex (R) Supercharger, fabricado pela empresa, é o compressor automotivo mais eficiente do mundo; Estudo com carvão destaca o potencial do carvão térmico com qualidade de exportação da Aviva Corporation Limited (ASX:AVA), projeto Mmamantswe em Botsuana; EnviroGold Limited (ASX:EVG) reforçou sua administração na América Latina; Phosphagenics Limited (ASX:POH) anunciou colaboração para desenvolver medicamento contra a psoríase nos EUA.